San Francisco – March 16, 2016 – BioPharm Insight League Tables ranked Cooley #1 in biotech & pharma licensing for both value and volume across the following categories:
- 2015 Global BioPharm Insight Licensing League Table; 23 deals, $7.8 billion
- 2015 North America Licensing League Table; 22 deals, $7.8 billion
- Q4 2015 Licensing League Table; 13 deals, $3.4 billion
"These rankings demonstrate Cooley's continued prominence in the life sciences sector," said Barbara Kosacz, partner and head of the firm's life sciences practice. "We have a talented group of individuals whose collective knowledge and expertise in the field help achieve unparalleled success for our clients."
Earlier this month, for the third year in a row, Cooley was ranked the #1 most active law firm for life sciences venture financings according to data from VentureSource.
About Cooley LLP
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.
Cooley has 900 lawyers across 12 offices in the United States, China and Europe.